IRAK3 and coronary artery disorder: MicroRNA-539-5p, one of the EAT-derived miRNAs increased in CAD patients [85], has been reported to target interleukin 1 receptor associated kinase 3 (IRAK3) and thereby inhibit inflammatory injury in cardiomyocytes [121].